Virtu Financial’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,002
| Closed | -$252K | – | 1390 |
|
|
2023
Q4 | $252K | Sell |
2,002
-993
| -33% | -$125K | 0.02% | 689 |
|
|
2023
Q3 | $280K | Buy |
+2,995
| New | +$280K | 0.03% | 533 |
|
|
2022
Q2 | – | Sell |
-1,771
| Closed | -$208K | – | 1567 |
|
|
2022
Q1 | $208K | Sell |
1,771
-1,787
| -50% | -$210K | 0.02% | 760 |
|
|
2021
Q4 | $479K | Buy |
+3,558
| New | +$479K | 0.05% | 391 |
|
|
2021
Q3 | – | Sell |
-1,682
| Closed | -$221K | – | 1483 |
|
|
2021
Q2 | $221K | Buy |
+1,682
| New | +$221K | 0.02% | 927 |
|
|
2020
Q4 | – | Sell |
-1,787
| Closed | -$276K | – | 1426 |
|
|
2020
Q3 | $276K | Buy |
+1,787
| New | +$276K | 0.05% | 469 |
|
|
2019
Q3 | – | Sell |
-5,483
| Closed | -$631K | – | 1412 |
|
|
2019
Q2 | $631K | Buy |
5,483
+3,519
| +179% | +$405K | 0.04% | 433 |
|
|
2019
Q1 | $231K | Buy |
+1,964
| New | +$231K | 0.01% | 913 |
|
|
2018
Q2 | – | Sell |
-3,478
| Closed | -$227K | – | 1962 |
|
|
2018
Q1 | $227K | Buy |
+3,478
| New | +$227K | 0.01% | 1262 |
|